Brian Dougherty

30.8k citations
60 papers · 5.0k indexed · 4 hit papers · h-index 25
Topics
PARP inhibition in cancer therapy (18 papers)Cancer Genomics and Diagnostics (15 papers)BRCA gene mutations in cancer (11 papers)

In The Last Decade

Brian Dougherty

58 papers receiving 4.9k citations

Hit Papers

Acquired EGFR C797S mutation mediates resistance to AZD92...201420262018202220152014201620142505007501000

Peers

Brian Dougherty
Comparison fields: 5 of 119
  • Oncology 2.5k
  • Molecular Biology 2.4k
  • Pulmonary and Respiratory Medicine 1.3k
  • Cancer Research 1.1k
  • Reproductive Medicine 960
Replace Maria I. Harrell with:
Maria I. Harrell United States
Paul B. Mullan United Kingdom
Raffit Hassan United States
Karl Ziegelbauer Germany
Jérôme Solassol France
María J. García Spain
Wenxin Zheng United States
Alan Lamont United Kingdom
Stefan Zimmermann Switzerland
Steven M. Ruben United States
Brian Dougherty relative to Maria I. Harrell United States Maria I. Harrell's profile →
Citations per field
00.5×5.6×
Maria I. Harrell · 1×
Citations per year

Countries citing papers authored by Brian Dougherty

Since Specialization
Citations

This map shows the geographic impact of Brian Dougherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Dougherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Dougherty more than expected).

Fields of papers citing papers by Brian Dougherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Dougherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Dougherty. The network helps show where Brian Dougherty may publish in the future.

Co-authorship network of co-authors of Brian Dougherty

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Dougherty. A scholar is included among the top collaborators of Brian Dougherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Dougherty. Brian Dougherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 13
4 1
5 2
6 167
7 3
8 23
9 59
10 14
11
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialbreakdown →
1060
12 30
13 4
14 38
15 67
16 27
17 9
18 106
19 124
20 42

About Brian Dougherty

Brian Dougherty is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 60 papers that have together received 5.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (18 papers), Cancer Genomics and Diagnostics (15 papers) and BRCA gene mutations in cancer (11 papers). The work is most often cited by research in Reproductive Medicine (960 citations), Oncology (2.5k citations) and Cancer Research (1.1k citations). Brian Dougherty has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include J. Carl Barrett, I van de Rijn, Zhongwu Lai, Aleksandra Markovets, Daniel Stetson, Darren Hodgson, Michael Friedländer, Maria Orr, Pasi A. Jänne and Jonathan A. Ledermann. Their work appears in journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026